Northern Trust’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.8M Sell
552,018
-1,085
-0.2% -$30.6K ﹤0.01% 1899
2025
Q4
$17.4M Buy
553,103
+56,653
+11% +$1.88M ﹤0.01% 1763
2025
Q3
$17.7M Sell
496,450
-10,701
-2% -$489K ﹤0.01% 1770
2025
Q2
$29.2M Buy
507,151
+74,204
+17% +$4.2M ﹤0.01% 1425
2025
Q1
$25.2M Sell
432,947
-13,521
-3% -$923K ﹤0.01% 1488
2024
Q4
$35.9M Buy
446,468
+60,098
+16% +$5.13M 0.01% 1329
2024
Q3
$31M Buy
386,370
+27,621
+8% +$1.96M 0.01% 1349
2024
Q2
$21.9M Sell
358,749
-7,675
-2% -$456K ﹤0.01% 1495
2024
Q1
$18.1M Sell
366,424
-11,454
-3% -$545K ﹤0.01% 1654
2023
Q4
$15.8M Buy
377,878
+25,741
+7% +$877K ﹤0.01% 1774
2023
Q3
$11.6M Buy
352,137
+22,773
+7% +$776K ﹤0.01% 1895
2023
Q2
$11.6M Buy
329,364
+90,200
+38% +$2.98M ﹤0.01% 1949
2023
Q1
$6.79M Buy
239,164
+4,661
+2% +$164K ﹤0.01% 2277
2022
Q4
$9.74M Buy
234,503
+5,419
+2% +$233K ﹤0.01% 2029
2022
Q3
$9.5M Buy
229,084
+38,159
+20% +$1.52M ﹤0.01% 2007
2022
Q2
$6.24M Buy
190,925
+125,953
+194% +$4.58M ﹤0.01% 2355
2022
Q1
$2.27M Sell
64,972
-1,089
-2% -$26.2K ﹤0.01% 3036
2021
Q4
$1.65M Buy
+66,061
New +$2.44M ﹤0.01% 3318

Other funds holding PRCT

Northern Trust's PRCT Position: Q1 2026 in Review

Northern Trust reduced its Procept Biorobotics (PRCT) stake by 0.2% in Q1 2026, selling an estimated $30.6K and leaving 552,018 shares worth $13.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1899.

Northern Trust first reported a position in PRCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $35.9M in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Northern Trust held 552,018 shares of Procept Biorobotics worth $13.8M as of Q1 2026.
  • Northern Trust sold 1,085 Procept Biorobotics shares in Q1 2026, an estimated $30.6K.
  • Procept Biorobotics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1899 holding.
  • Northern Trust first reported a position in Procept Biorobotics in Q4 2021 and has held it in 18 quarters since.
  • Northern Trust's Procept Biorobotics position peaked at $35.9M in Q4 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.